RenovoRx RNXT
$
Relative Strength Index (RSI)
- The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. It is typically used to identify overbought or oversold conditions in financial markets.
- The RSI is calculated using the following formula:
RSI = 100 - (100 / (1 + RS))
Where RS is the ratio of the average gains to the average losses over a specified period.
- The default time period used is 14 days.
- RSI values range between 0 and 100.
RSI values above 70 are considered overbought (indicating a potentially opportune time to sell)
RSI values below 30 are considered oversold (indicating a potentially opportune time to buy)
RSI is not a perfect indicator and should be used in conjunction with other technical analysis tools, this is for informational purposes only and is not a substitute for professional financial advice.
About
RenovoRx (RNXT) Business Model and Operations Summary
RenovoRx, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapies for the treatment of solid tumors. Its lead product candidate is RenovoGem, a drug and device combination consisting of intra-arterial gemcitabine and RenovoCath that is in Phase III clinical trials for the locally advanced pancreatic cancer. RenovoRx, Inc. was founded in 2009 and is headquartered in Los Altos, California.
Key Insights
RenovoRx (RNXT) Core Market Data and Business Metrics
Latest Closing Price
$1.4Market Cap
$45.35 MillionAverage Trade Volume
138,953 SharesTotal Outstanding Shares
36.57 Million SharesCEO
Mr. Shaun R. BagaiTotal Employees
10IPO Date
August 26, 2021SIC Description
Pharmaceutical PreparationsPrimary Exchange
NASDAQHeadquarters
2570 W. El Camino Real, Ste. 320,, Mountain View, CA, 94040
Earnings Reports
Expected vs. Actual Quarterly Earnings-Per-Share & Revenue
Short Volume
Daily short volume activity identifies short-term trading pressure and potential price volatility
Revenue Breakdown
Distribution of revenue across unique business segments & geographies
Historical Stock Splits
Execution Date | Split Amount |
---|